Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
批准号:
10594957
负责人:
Lifang Hou
金额:
$23.58万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-05-09 至 2025-03-31
关键词:
AIDS related cancerAddressAfrica South of the SaharaAfricanAgingAreaAwardBioinformaticsBiological MarkersBiometryClinical DataCollaborationsCollectionCountryDistance LearningDoctor of PhilosophyEducational workshopEpidemicEpidemiologistFundingGoalsHIVHealth Services ResearchIncidenceInstitutionInterdisciplinary StudyLaboratoriesMalignant NeoplasmsMaster of ScienceMedicalMedical InformaticsMentorsMentorshipMolecularMolecular EpidemiologyMolecular Epidemiology of CancerMorbidity - disease rateNigeriaNigerianOncogenicOutcomes ResearchPopulationPopulation StudyPreventionPreventiveProtocols documentationResearchResearch Project GrantsResearch TrainingScientistSiteTherapeuticTrainingTraining ProgramsUnited States National Institutes of HealthUniversitiesViralantiretroviral therapycancer epidemiologyclinical investigationco-infectiondesignepidemiology studyepigenomicsimprovedinnovationlow and middle-income countriesmortalitypopulation basedprogramssenior faculty
中文摘要
项目摘要
西北/尼日利亚艾滋病毒和艾滋病研究培训计划(NN-HAM)解决了一个高风险的问题。
由于艾滋病毒的广泛传播,美国国立卫生研究院的优先研究领域和撒哈拉以南非洲的重大问题
致癌病毒合并感染的高负担使流行病变得更糟。抗逆转录病毒治疗项目
由PEPFAR、全球基金和其他机构实施的艾滋病毒/艾滋病紧急救援计划,
发病率和死亡率;然而,随着人口老龄化,某些恶性肿瘤的发病率正在上升。最
非洲的医疗和研究机构对应对这些新出现的挑战准备不足。自2014年以来,
西北大学和尼日利亚乔斯大学成功合作开展了一项研究培训
艾滋病毒和恶性肿瘤计划(西北和乔斯大学艾滋病毒和
恶性肿瘤,D43 TW 009575)。课程亮点包括:2个硕士学位水平的临床研究
培训了科学家和2名卫生服务和成果研究博士;高级教师进修;以及6名
飞行学员奖励。我们进一步与西北大学、拉各斯大学和
乔斯大学成功竞争NCI资助的U 54(艾滋病毒相关的表观基因组生物标志物)
尼日利亚的癌症,1U 54 CA 221205)。本次更新福格蒂艾滋病毒研究培训计划的中低收入国家
一项提案将进一步提高尼日利亚科学家进行大规模人群艾滋病毒恶性肿瘤研究的能力
通过培训专注于癌症分子流行病学的科学家。我们的主要假设是
在HIV相关恶性肿瘤的分子癌症流行病学、生物统计学和生物信息学方面的能力
将显著增强我们对癌症流行病学的理解,并促进基于生物标志物的机制
研究将为预防和治疗策略提供信息,最终导致癌症减少
发病率和死亡率。本续期申请的具体目的是:1.训练癌分子
流行病学家能够:i)设计和进行基于人群的分子流行病学研究,ii)
开发用于生物样本收集、处理和储存的方案,以及iii)开发生物标记物,所述生物标记物
可用于预防和改善HIV相关恶性肿瘤的治疗; 2.培养多名硕士
学位水平的生物统计学家和科学家在医学信息学和生物信息学谁可以管理和
处理来自临床、实验室和人群环境的数据,并进行全面的生物统计和
由大群体研究产生的生物信息学分析;以及3.创建多学科研究团队
能够进行先进的国内分子流行病学研究,包括高通量“组学”
在我们的网络站点乔斯大学和拉各斯大学开展艾滋病毒相关恶性肿瘤研究。我们
我将通过强有力的指导和研究培训,包括实现我们的目标:1博士学位和4个硕士学位
学位(长期),3个中期研究项目驱动的培训方案,几个短期国内
创新的远程教育。
英文摘要
PROJECT SUMMARY
The Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM) addresses a high
priority NIH research area and significant problem in sub-Saharan Africa because of the widespread HIV
epidemic made worse by the high burden of oncogenic viral co-infections. Antiretroviral therapy programs put
into place by PEPFAR, the Global Fund and others, have resulted in a remarkable decrease in HIV-related
morbidity and mortality; however, the rate of certain malignancies are rising while the population is aging. Most
African medical and research institutions are ill-prepared to confront these emerging challenges. Since 2014,
Northwestern University and University of Jos in Nigeria successfully collaborated in a research training
program for HIV and malignancies (Northwestern and Jos University Research Training Program in HIV and
Malignancies, D43 TW009575). Program highlights include: 2 master's degree-level Clinical Investigation
scientists and 2 PhDs in Health Services & Outcomes Research trained; senior faculty enrichment; and 6
mentored trainee pilot awards. We further formed a network with Northwestern, University of Lagos, and
University of Jos to successfully compete for an NCI-funded U54 (Epigenomic Biomarkers of HIV-Associated
Cancers in Nigeria, 1U54CA221205). This renewal Fogarty HIV Research Training Program for LMICs
proposal will further enhance Nigerian scientists' capacity for large population-based HIV-malignancy research
by training scientists focused on cancer molecular epidemiology. Our primary hypothesis is that building
capacity in molecular cancer epidemiology, biostatistics, and bioinformatics on HIV-associated malignancies
will significantly enhance our understanding of cancer epidemiology and promote mechanistic biomarker-based
research that will inform preventive and therapeutic strategies, ultimately leading to a reduction in cancer
incidence and mortality. This renewal application's specific aims are to: 1. train cancer molecular
epidemiologists capable of: i) designing and conducting population-based molecular epidemiology studies, ii)
developing protocols for biospecimen collection, processing, and storage, and iii) developing biomarkers that
can be used for prevention and improved treatment of HIV-associated malignancies; 2. train several master's
degree-level biostatisticians and scientists in medical informatics and bioinformatics who can manage and
handle data from clinical, laboratory, and population settings, and perform comprehensive biostatistical and
bioinformatic analyses generated from large population studies; and 3. create a multidisciplinary research team
capable of performing advanced in-country molecular epidemiology research, including high throughput “omic”
research, on HIV-associated malignancies at our network sites, University of Jos and University of Lagos. We
will achieve our goals through strong mentorship and research training including: 1 PhD degree and 4 master's
degrees (long-term), 3 medium-term research-project-driven training programs, several short-term in-country
workshops, and innovative distance learning.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.7189/jogh.12.03075
发表时间:
2022-12-16
期刊:
Journal of global health
影响因子:
7.2
作者:
[Akiyode-Afolabi A, Ogwezzy-Ndisika A, Christian E, Okonkwo A, Klein K, Brown S, Kamau N, Murphy R, Hou L, Ogunsola F]
通讯作者:
Ogunsola F
DOI:
10.1186/s13027-022-00424-4
发表时间:
2022-03-21
期刊:
Infectious agents and cancer
影响因子:
3.7
作者:
[Akanbi MO, Bilaver LA, Achenbach C, Hirschhorn LR, Rivera AS, Silas OA, Agaba PA, Agbaji O, Shehu NY, Sagay SA, Hou L, Murphy RL]
通讯作者:
Murphy RL
DOI:
10.7189/jogh.13.03010
发表时间:
2023-04-14
期刊:
Journal of global health
影响因子:
7.2
作者:
[Musa J, Magaji FA, Ali MJ, Okolo M, Silas OA, Imade GE, Green SJ, Mehta SD, Hou L, Murphy RL]
通讯作者:
Murphy RL
DOI:
10.3389/fpubh.2022.834800
发表时间:
2022
期刊:
FRONTIERS IN PUBLIC HEALTH
影响因子:
5.2
作者:
[Musa, Jonah, Kim, Kyeezu, Zheng, Yinan, Qu, Yishu, Joyce, Brian T., Wang, Jun, Nannini, Drew R., Gursel, Demirkan B., Silas, Olugbenga, Abdulkareem, Fatimah B., Imade, Godwin, Akanmu, Alani S., Wei, Jian-Jun, Kocherginsky, Masha, Kim, Kwang-Youn A., Wehbe, Firas, Achenbach, Chad J., Anorlu, Rose, Simon, Melissa A., Sagay, Atiene, Ogunsola, Folasade T., Murphy, Robert L., Hou, Lifang]
通讯作者:
Hou, Lifang
Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.
尼日利亚乔斯资源有限的环境中艾滋病毒相关淋巴瘤的结果。
DOI:
10.1186/s13027-017-0144-7
发表时间:
2017
期刊:
Infectious agents and cancer
影响因子:
3.7
作者:
[Silas,OlugbengaAkindele, Achenbach,ChadJ, Hou,Lifang, Murphy,RobertL, Egesie,JulieO, Sagay,SolomonA, Agbaji,OcheO, Agaba,PatriciaE, Musa,Jonah, Manasseh,AgabusN, Jatau,EzraD, Dauda,AyubaM, Akanbi,MaxwellO, Mandong,BarnabasM]
通讯作者:
Mandong,BarnabasM
共 17 条
Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria
-
批准号:10530153
-
项目类别:
-
资助金额:$74.35万
-
财政年份:2022
-
负责人:Lifang Hou
-
依托单位:
Epigenomic landscape of individual- and neighborhood-level social disadvantages and cardiovascular health disparity
-
批准号:10701077
-
项目类别:
-
资助金额:$52.94万
-
财政年份:2022
-
负责人:Lifang Hou
-
依托单位:
Epigenomic landscape of individual- and neighborhood-level social disadvantages and cardiovascular health disparity
-
批准号:10531486
-
项目类别:
-
资助金额:$56.95万
-
财政年份:2022
-
负责人:Lifang Hou
-
依托单位:
Epigenetic biomarkers of Cervical HPV in women with oral and oropharyngeal HPV, precancer and cancer
-
批准号:10841283
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2022
-
负责人:Lifang Hou
-
依托单位:
Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria
-
批准号:10705727
-
项目类别:
-
资助金额:$82.55万
-
财政年份:2022
-
负责人:Lifang Hou
-
依托单位:
Infection-Associated Cancer Research Training Program in Mali
-
批准号:10440364
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2021
-
负责人:Lifang Hou
-
依托单位:
Infection-Associated Cancer Research Training Program in Mali
-
批准号:10645169
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2021
-
负责人:Lifang Hou
-
依托单位:
Infection-Associated Cancer Research Training Program in Mali
-
批准号:10223788
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2021
-
负责人:Lifang Hou
-
依托单位:
High Dimensional Mediation Analysis for DNA Methylation Markers Mediating Cardiovascular Health Metrics and Cardiovascular Diseases
-
批准号:9918838
-
项目类别:
-
资助金额:$23.62万
-
财政年份:2019
-
负责人:Lifang Hou
-
依托单位:
Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria
-
批准号:10242887
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2017
-
负责人:Lifang Hou
-
依托单位:
Administrative Core
-
批准号:10242888
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2017
-
负责人:Lifang Hou
-
依托单位:
Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer
-
批准号:8881578
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2015
-
负责人:Lifang Hou
-
依托单位:
Northwestern and Jos University Research Training Program in HIV and Malignancies
-
批准号:8847822
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
-
批准号:9769446
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
-
批准号:9919014
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
-
批准号:10254305
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Northwestern and Jos University Research Training Program in HIV and Malignancies
-
批准号:9044841
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Epidemiology and Outcomes of HIV-associated Cancer
-
批准号:9297960
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)
-
批准号:10377570
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2014
-
负责人:Lifang Hou
-
依托单位:
DNA methylation alterations in response to pesticides exposure
-
批准号:7940848
-
项目类别:
-
资助金额:$49.52万
-
财政年份:2009
-
负责人:Lifang Hou
-
依托单位:
海外基金